Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Kinarus Therapeutics Holding AG
LSE:0QNS
Kinarus Therapeutics Holding AG
LSE:0QNS
Price:
0.0154
CHF
-38.4%
Market Closed
Market Cap:
CHf81.8k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Kinarus Therapeutics Holding AG
LSE:0QNS
|
CH |
|
R
|
Realty Income Corp
SWB:RY6
|
US |
|
Laboratory Corporation of America Holdings
BMV:LH
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0QNS's stock price target?
Not Available
0QNS does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Kinarus Therapeutics Holding AG?
Projected CAGR
77%
77%
Over the last 8 years, the compound annual growth rate for Revenue has been -6%. The projected CAGR for the next 3 years is 77%.
What is the Gross Profit forecast for Kinarus Therapeutics Holding AG?
Projected CAGR
146%
146%
Over the last 8 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 3 years is 146%.